(Q36764604)

16 August 2017

1 reference

title

Combination therapy for the treatment of ocular neovascularization (English)

1 reference

16 August 2017

1 reference

John Bradley

1

1 reference

16 August 2017

Meihua Ju

series ordinal

2

1 reference

16 August 2017

Gregory S Robinson

series ordinal

3

1 reference

16 August 2017

publication date

13 March 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

10

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

141-148

1 reference

https://scigraph.springernature.com/pub.10.1007/s10456-007-9069-x

16 August 2017

exact match

0 references

cites work

Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1007%2FS10456-007-9069-X

Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-007-9069-X

Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-007-9069-X

Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-007-9069-X

Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-007-9069-X

10.1007/S10456-007-9069-X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference